Femara 2.5Mg Tablet 30'S

• Femara 2.5mg contains letrozole an aromatase inhibitor for breast cancer management • Indicated for hormone receptor positive early and advanced breast cancer • Prescribed for postmenopausal women under specialist oncologist supervision • Film coated Tabletlet for once daily oral administration as directed by a physician • Requires a valid prescription from a licensed oncologist or physician for dispensing • Available at Medon Pharmacy UAE

Femara 2.5mg Tabletlets contain letrozole, a third-generation aromatase inhibitor prescribed for the treatment of hormone receptor-positive breast cancer in postmenopausal women. Taken once daily under oncologist supervision to reduce oestrogen production and slow cancer growth. Benefits: • Supports hormone receptor positive breast cancer treatment in postmenopausal women • Helps reduce oestrogen production by inhibiting peripheral aromatase enzyme activity • Promotes slowing of breast cancer growth through consistent oestrogen suppression • Relieves the hormonal stimulus driving oestrogen-responsive breast cancer progression • SuiTabletle for postmenopausal women with HR+ breast cancer as prescribed by an oncologist How to Use: • Take one Tabletlet once daily at the same time each day with or without food • Swallow whole with a glass of water and do not crush or chew the Tabletlet • Continue treatment as directed by your oncologist for the recommended duration • Attend regular oncology reviews and bone health monitoring appointments • Store in a cool dry place away from moisture and out of reach of children